Skip to main content

Advertisement

Log in

Serum Arginase II level can be a novel indicator for erectile dysfunction in patients with vasculogenic erectile dysfunction: a comparative study

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of the study was to compare serum level of Arginase II in patients with vasculogenic erectile dysfunction (ED) versus healthy controls and to assess if its level is affected by severity of ED.

Methods

This is a prospective study that compared Arginase II in 40 patients with ED versus 40 healthy controls. Patients were excluded if they had any pelvic trauma or pelvic surgery, hormonal disorders, Peyronie’s disease, smoking, drug addiction or systemic illnesses. ED was evaluated by the validated Arabic version of the abbreviated five-item form of the international index of erectile function (IIEF-5). Serum arginase II level was assayed using ELIZA. Mann–Whitney, Kruskal–Wallis and Chi-square tests and Spearman correlation were used as appropriate and confirmed by logistic regression model.

Results

22 (55%) patients had DM. 15 (37.5%), 7 (17%), 6 (15%) and 12 (30%) patients suffered from severe, moderate, mild to moderate and mild ED, respectively. The level of serum Arginase II was significantly higher in patients than controls (p < 0.001) and confirmed by multivariate logistic regression analysis. It also correlated significantly with age (r2 = 0.22; p < 0.001) and IIEF-5 score (r2 = 0.8; p < 0.001). Serum Arginase II increased significantly with more severe ED (p < 0.001). Arginase II was also significantly higher in diabetic patients (p < 0.001).

Conclusion

Serum level of Arginase II is significantly higher in patients with vasculogenic ED compared to healthy controls. It correlates significantly with age and IIEF-5 and was significantly affected by the severity of ED.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. NIH Consensus Development Panel on Impotence (1993) Impotence. JAMA 270:83–90

    Article  Google Scholar 

  2. Cassidy A, Franz M, Rim EB (2016) Dietary flavonoid intake and incidence of erectile dysfunction. Am J Clin Nutr 103(2):534–541. https://doi.org/10.3945/ajcn.115.122010

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Dean RC, Lue TF (2005) Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin N Am 32(4):379–395

    Article  Google Scholar 

  4. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ (2004) Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 43(2):179–184

    Article  PubMed  Google Scholar 

  5. Lacchini R, Muniz JJ, Nobre YT, Cologna AJ, Martins AC, Tanus-Santos JE (2015) Relationship between arginase 1 and arginase 2 levels and genetic polymorphisms with erectile dysfunction. Nitric Oxide 51:36–42. https://doi.org/10.1016/j.niox.2015.10.003

    Article  PubMed  CAS  Google Scholar 

  6. De A, Singh MF, Singh V, Ram V, Bisht S (2016) Treatment effect of L-norvaline on the sexual performance of male rats with streptozotocin induced diabetes. Eur J Pharmacol 771:247–254. https://doi.org/10.1016/j.ejphar.2015.12.008

    Article  PubMed  CAS  Google Scholar 

  7. Di Costanzo L, Pique ME, Christianson DW (2007) Crystal structure of human arginase I complexed with thiosemicarbazide reveals an unusual thiocarbonyl mu-sulfide ligand in the binuclear manganese cluster. J Am Chem Soc 129(20):6388–6389

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Musicki B, Burnett AL (2006) eNOS function and dysfunction in the penis. Exp Biol Med 231(2):154–165 (Review)

    Article  CAS  Google Scholar 

  9. Durante W, Johnson FK, Johnson RA (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34(9):906–911 (Review)

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Pernow J, Jung C (2013) Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res 98(3):334–343. https://doi.org/10.1093/cvr/cvt036

    Article  PubMed  CAS  Google Scholar 

  11. Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC (2001) Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 283(4):923–927

    Article  PubMed  CAS  Google Scholar 

  12. Cox JD, Kim NN, Traish AM, Christianson DW (1999) Arginase-boronic acid complex highlights a physiological role in erectile function. Nat Struct Biol 6(11):1043–1047

    Article  PubMed  CAS  Google Scholar 

  13. Cama E, Colleluori DM, Emig FA et al (2003) Human arginase II: crystal structure and physiological role in male and female sexual arousal. Biochemistry 42(28):8445–8451

    Article  PubMed  CAS  Google Scholar 

  14. Prieto CP, Krause BJ, Quezada C, San Martin R, Sobrevia L, Casanello P (2011) Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistributionin human umbilical vein endothelium. Placenta 32(12):932–940. https://doi.org/10.1016/j.placenta.2011.09.003

    Article  PubMed  CAS  Google Scholar 

  15. Berkowitz DE, White R, Li D et al (2003) Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108(16):2000–2006

    Article  PubMed  CAS  Google Scholar 

  16. Shamloul R, Ghanem H, Abou-zeid A (2004) Validity of the Arabic version of the sexual health inventory for men among Egyptians. Int J Impot Res 16(5):452–455

    Article  PubMed  CAS  Google Scholar 

  17. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11(6):319–326

    Article  PubMed  CAS  Google Scholar 

  18. Ogino K, Murakami I, Wang DH et al (2013) Evaluation of serum arginase I as an oxidative stress biomarkerin a healthy Japanese population using a newly established ELISA. Clin Biochem 46(16–17):1717–1722. https://doi.org/10.1016/j.clinbiochem.2013.08.012

    Article  PubMed  CAS  Google Scholar 

  19. Xie D, Kontos CD, Donatucci CF, Annex BH (2005) Cholesterol feeding reduces vascular endothelial growth factor signaling in rabbit corporal tissues. J Sex Med 2(5):634–640

    Article  PubMed  CAS  Google Scholar 

  20. Hink U, Li H, Mollnau H et al (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88(2):E14–E22

    Article  PubMed  CAS  Google Scholar 

  21. Grein U, Schubert GE (2002) Arteriosclerosis of penile arteries: histological findings and their significance in the treatment of erectile dysfunction. Urol Int 68(4):261–264

    Article  PubMed  Google Scholar 

  22. Barassi A, Corsi Romanelli MM, Pezzilli R et al (2017) Levels of l-arginine and l-citrulline in patients with erectile dysfunction of different etiology. Andrology 5(2):256–261. https://doi.org/10.1111/andr.12293

    Article  PubMed  CAS  Google Scholar 

  23. Mirea O, Donoiu I, Pleşea IE (2012) Arterial aging: a brief review. Rom J Morphol Embryol 53(3):473–477 (Review)

    PubMed  Google Scholar 

  24. Ryoo S, Gupta G, Benjo A et al (2008) Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 102(8):923–932. https://doi.org/10.1161/CIRCRESAHA.107.169573

    Article  PubMed  CAS  Google Scholar 

  25. Gorenne I, Kavurma M, Scott S, Bennett M (2006) Vascular smooth muscle cell senescence in atherosclerosis. Cardiovasc Res 72(1):9–17

    Article  PubMed  CAS  Google Scholar 

  26. Sun C, Sun L, Ma H et al (2012) The phenotype and functional alterations of macrophages in mice with hyperglycemia for longterm. J Cell Physiol 227(4):1670–1679. https://doi.org/10.1002/jcp.22891

    Article  PubMed  CAS  Google Scholar 

  27. Morita M, Hayashi T, Ochiai M et al (2014) Oral supplementation with a combination of L-citrulline and L-arginine rapidly increases plasma L-arginine concentration and enhances NO bioavailability. Biochem Biophys Res Commun 454(1):53–57. https://doi.org/10.1016/j.bbrc.2014.10.029

    Article  PubMed  CAS  Google Scholar 

  28. Shiota A, Hotta Y, Kataoka T, Morita M, Maeda Y, Kimura K (2013) Oral L-citrulline supplementation improves erectile function in rats with acute arteriogenicerectile dysfunction. J Sex Med 10(10):2423–2429. https://doi.org/10.1111/jsm.12260

    Article  PubMed  CAS  Google Scholar 

  29. Cormio L, De Siati M, Lorusso F et al (2011) Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology 77(1):119–122. https://doi.org/10.1016/j.urology.2010.08.028

    Article  PubMed  Google Scholar 

  30. Lacchini R, Muniz JJ, Nobre YT, Cologna AJ, Martins AC, Tanus-Santos JE (2017) Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. Pharmacogenom J. https://doi.org/10.1038/tpj.2017.2 (Epub ahead of print)

    Article  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammed Said ElSheemy.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local ethical committee.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdel Wahed, A.S.A.H., Amer, M.A., Abou Mohamed, N.M. et al. Serum Arginase II level can be a novel indicator for erectile dysfunction in patients with vasculogenic erectile dysfunction: a comparative study. Int Urol Nephrol 50, 1389–1395 (2018). https://doi.org/10.1007/s11255-018-1921-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-018-1921-y

Keywords

Navigation